Cargando…

CSF T-Tau/Aβ(42) Predicts White Matter Microstructure in Healthy Adults at Risk for Alzheimer’s Disease

Cerebrospinal fluid (CSF) biomarkers T-Tau and Aβ(42) are linked with Alzheimer’s disease (AD), yet little is known about the relationship between CSF biomarkers and structural brain alteration in healthy adults. In this study we examined the extent to which AD biomarkers measured in CSF predict bra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bendlin, Barbara B., Carlsson, Cynthia M., Johnson, Sterling C., Zetterberg, Henrik, Blennow, Kaj, Willette, Auriel A., Okonkwo, Ozioma C., Sodhi, Aparna, Ries, Michele L., Birdsill, Alex C., Alexander, Andrew L., Rowley, Howard A., Puglielli, Luigi, Asthana, Sanjay, Sager, Mark A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368882/ https://www.ncbi.nlm.nih.gov/pubmed/22701578 http://dx.doi.org/10.1371/journal.pone.0037720

Ejemplares similares

Microstructural white matter alterations in preclinical Alzheimer’s disease detected using free water elimination diffusion tensor imaging
por: Hoy, Andrew R., et al.
Publicado: (2017)

NSAIDs May Protect Against Age-Related Brain Atrophy
por: Bendlin, Barbara B., et al.
Publicado: (2010)

Low cerebral blood flow is associated with lower memory function in metabolic syndrome
por: Birdsill, Alex C, et al.
Publicado: (2013)

An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum
por: Van Hulle, Carol, et al.
Publicado: (2020)

AD‐associated CSF biomolecular changes are attenuated in KL‐VS heterozygotes
por: Driscoll, Ira, et al.
Publicado: (2022)

Insulin Resistance, Brain Atrophy, and Cognitive Performance in Late Middle–Aged Adults
por: Willette, Auriel A., et al.
Publicado: (2013)

Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer’s disease
por: Miners, James, et al.
Publicado: (2023)

Moderate intensity physical activity associates with CSF biomarkers in a cohort at risk for Alzheimer's disease
por: Law, Lena L., et al.
Publicado: (2018)

Cerebrospinal fluid ratios with Aβ(42) predict preclinical brain β-amyloid accumulation
por: Racine, Annie M., et al.
Publicado: (2015)

Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation
por: Racine, Annie M., et al.
Publicado: (2014)

CSF metabolites associate with CSF tau and improve prediction of Alzheimer's disease status
por: Dong, Ruocheng, et al.
Publicado: (2021)

White matter microstructure in late middle-age: Effects of apolipoprotein E4 and parental family history of Alzheimer's disease
por: Adluru, Nagesh, et al.
Publicado: (2014)

Impact of sex and APOE ε4 on age-related cerebral perfusion trajectories in cognitively asymptomatic middle-aged and older adults: A longitudinal study
por: Wang, Rui, et al.
Publicado: (2021)

Subjective memory complaints, cortical thinning, and cognitive dysfunction in middle-age adults at risk of AD
por: Schultz, Stephanie A., et al.
Publicado: (2015)

Crosswalk study on blood collection‐tube types for Alzheimer's disease biomarkers
por: Jonaitis, Erin M., et al.
Publicado: (2022)

Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum
por: Allison, Samantha L., et al.
Publicado: (2019)

CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau
por: Henjum, Kristi, et al.
Publicado: (2018)

CSF metabolites associated with biomarkers of Alzheimer’s disease pathology
por: Dong, Ruocheng, et al.
Publicado: (2023)

Age-related differences in white matter microstructure measured by advanced diffusion MRI in healthy older adults at risk for Alzheimer’s disease
por: Motovylyak, Alice, et al.
Publicado: (2022)

Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease
por: Mattsson, Niklas, et al.
Publicado: (2014)

Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer's disease in non‐demented adults
por: Ennis, Gilda E., et al.
Publicado: (2021)

Differential effects of neurodegeneration biomarkers on subclinical cognitive decline
por: Merluzzi, Andrew P., et al.
Publicado: (2019)

The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease
por: Vogt, Nicholas M., et al.
Publicado: (2018)

Cardiorespiratory fitness attenuates age-associated aggregation of white matter hyperintensities in an at-risk cohort
por: Vesperman, Clayton J., et al.
Publicado: (2018)

Comparative Evaluation of MS-based Metabolomics Software and Its Application to Preclinical Alzheimer’s Disease
por: Hao, Ling, et al.
Publicado: (2018)

Intracranial arterial four-dimensional flow is associated with metrics of brain health and Alzheimer's disease
por: Berman, Sara E., et al.
Publicado: (2015)

Measurement batch differences and between‐batch conversion of Alzheimer's disease cerebrospinal fluid biomarker values
por: Ma, Yue, et al.
Publicado: (2021)

The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions
por: Johnson, Sterling C., et al.
Publicado: (2017)

Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease
por: Mattsson, Niklas, et al.
Publicado: (2010)

Cerebrospinal fluid biomarkers of neurofibrillary tangles and synaptic dysfunction are associated with longitudinal decline in white matter connectivity: A multi-resolution graph analysis
por: Kim, Won Hwa, et al.
Publicado: (2018)

Amyloid burden, cortical thickness, and cognitive function in the Wisconsin Registry for Alzheimer's Prevention
por: Doherty, Benjamin M., et al.
Publicado: (2015)

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
por: Janelidze, Shorena, et al.
Publicado: (2016)

Associations between diffusion MRI microstructure and cerebrospinal fluid markers of Alzheimer's disease pathology and neurodegeneration along the Alzheimer's disease continuum
por: Moody, Jason F., et al.
Publicado: (2022)

Brain volumetric and microstructural correlates of executive and motor performance in aged rhesus monkeys
por: Sridharan, Aadhavi, et al.
Publicado: (2012)

Asthma amplifies dementia risk: Evidence from CSF biomarkers and cognitive decline
por: Nair, Ajay Kumar, et al.
Publicado: (2022)

Impact of asthma on the brain: evidence from diffusion MRI, CSF biomarkers and cognitive decline
por: Nair, Ajay Kumar, et al.
Publicado: (2023)

Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia
por: Oh, Esther S., et al.
Publicado: (2018)

Gut microbiome alterations in Alzheimer’s disease
por: Vogt, Nicholas M., et al.
Publicado: (2017)

The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular events
por: Blennow, Kaj, et al.
Publicado: (2015)

Periodontal dysbiosis associates with reduced CSF Aβ42 in cognitively normal elderly
por: Kamer, Angela R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tmpp1hlbj9jt3sma9e2acf3r49